Analysis of Pooled Data from Two Randomized Controlled Trials and Their Open-Label Extensions: Long-Term Safety in Rheumatoid Arthritis before and after Certolizumab Pegol Dose Increase/Decrease

被引：0

作者：

Haraoui, Boulos ^{[1
]}

Bykerk, Vivian P. ^{[2
]}

van Vollenhoven, Ronald ^{[3
]}

de Longueville, Marc ^{[4
]}

Luijtens, Kristel ^{[4
]}

Ralston, Pauline ^{[5
]}

Kavanaugh, Arthur ^{[6
]}

机构：

[1] Ctr Hosp Univ Montreal, Montreal, PQ, Canada

[2] Hosp Special Surg, New York, NY 10021 USA

[3] Karolinska Inst, Stockholm, Sweden

[4] UCB Pharma, Brussels, Belgium

[5] Giant Profess Ltd, London, England

[6] Univ Calif San Diego, La Jolla, CA 92093 USA

来源：

ARTHRITIS & RHEUMATOLOGY | 2014年 / 66卷

关键词：

METHOTREXATE;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

464

引用

页码：S199 / S199

页数：1

共 4 条

[1]

Keystone E., 2013, Ann Rheum Dis

[2] Certolizumab Pegol Plus Methotrexate Is Significantly More Effective Than Placebo Plus Methotrexate in Active Rheumatoid Arthritis Findings of a Fifty-Two-Week, Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study [J].

Keystone, Edward ;

van der Heijde, Desiree ;

Mason, David, Jr. ;

Landewe, Robert ;

van Vollenhoven, Ronald ;

Combe, Bernard ;

Emery, Paul ;

Strand, Vibeke ;

Mease, Philip ;

Desai, Chintu ;

Pavelka, Karel .

ARTHRITIS AND RHEUMATISM, 2008, 58 (11) :3319-3329

[3] Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial [J].

Smolen, J. ;

Landewe, R. B. ;

Mease, P. ;

Brzezicki, J. ;

Mason, D. ;

Luijtens, K. ;

van Vollenhoven, R. F. ;

Kavanaugh, A. ;

Schiff, M. ;

Burmester, G. R. ;

Strand, V. ;

Vencovsky, J. ;

van der Heijde, D. .

ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (06) :797-804

[4]

Smolen JS, 2013, ARTHRITIS RHEUM-US, V65, pS988

← 1 →